Abstract
Exosomes are small membrane vesicles between 30 and 100 nm in diameter secreted by many cell types, and are associated with a wide range of physiological and/or pathological processes. Exosomes containing proteins, lipids, mRNA, and microRNA contribute to cell-to-cell communication and cell-to-environment regulation, however, their biological functions are not yet fully understood. In this report, exosomes in the glioblastoma cell line, U-87MG, were isolated and the proteome was investigated. In addition, exosome proteome changes in U-87MG cells exposed to a low temperature were investigated to elucidate whether the exosome proteome could respond to an external stimulus. Cell culture medium was collected, and exosomes were isolated by continuous centrifugation eliminating cell debris, nucleic acids, and other particles. The morphology of exosomes was observed by cryo-tunneling electron microscopy. According to 2-dimensional electrophoresis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry, certain proteins including collagen type VI alpha 1, putative RNA-binding protein 15B chain A, substrate induced remodeling of the active site regulates HTRA1, coatomer protein complex-subunit beta 2, myosin-heavy chain 1, and keratin-type I cytoskeletal 9 showed differences between the control proteome and the low temperature-exposed proteome.
Keywords: exosome, U-87MG, glioblastoma, proteome, external stimulus
1. Introduction
Small vesicles that are released by many cell types can be considered as tools for intercellular communication [1]. These mechanisms may occur via growth factors, cytokines, or small molecular mediators such as hormones, bioactive lipids, nucleotides, and several ions, which exchange information between cells [2,3,4,5]. Most cells shed their membrane-derived microvesicles (MVs) containing various proteins and lipids similar to their cells of origin [1]. In particular, among MVs, exosomes are an active subject of research due to their size and bioactivity, although their biological function has not yet been clarified [6].
Exosomes were first discovered in maturing mammalian reticulocytes, and are small membrane vesicles (30–100 nm) of endocytic origin that are released by a multitude of cell types as a consequence of the fusion of multivesicular bodies (MVBs) (late endosomes, lysosomes) with the plasma membrane [7,8]. Exosomes are secreted from the plasma membrane in two steps: “budding” and “shedding” [9]. They are formed in endocytic compartments (called MVBs) during endosome maturation by inward budding of their limiting membrane, and subsequently secreted into the extracellular milieu [10].
As a consequence of proteins and lipids being sorted at the limiting membrane of endosomes during the formation of intraluminal vesicles (ILVs) in MVBs, exosomes harbor a concrete set of molecules [11,12]. Previous research has shown that exosomes can deliver not only proteins but also mRNA, microRNA, and organelles (e.g., mitochondria), which mediate cell-to-cell communication [1]. They are thought to play a variety of roles such as cell stimulation, delivery of infectious agents into cells (e.g., prions and human immunodeficiency virus) [13,14], and as a biomarker for neurological disease (e.g., Alzheimer’s disease), depending on their origin [15].
According to recent research, exosomes can be harvested from the culture supernatant of several cell types of hematopoietic origin (B cells [16,17], mast cells [18,19], dendritic cells [20], T cells [21], and platelets [22]), as well as cells of non-hematopoietic origin (intestinal epithelial cells [23], Schwann cells [24], tumor cells [25], and neuronal cells [26]). In addition, there is increasing evidence for the presence of exosomes in physiological fluid such as saliva, plasma, breast milk [27,28], malignant and pleural effusions [28], amniotic fluid [29], cerebral spinal fluid [30], sperm [31], and urine [32].
In the present study, the human glioblastoma U-87MG cell line was used to demonstrate the presence of tumor-derived cell exosomes. The U-87MG glioma cell line represents grade IV glioblastoma, which is the most severe form of glioma [33]. The presence of U-87MG cell exosomes were confirmed, along with biochemical and transmission electron microscopy (TEM) evidence. These exosomes share biochemical and biophysical properties with exosomes from other cell types, including size, density, and canonical heat shock protein content [34]. Using Western blotting and gel-based proteomics, we have established both the commonality and uniqueness of the glioblastoma exosome proteome. Herein, cells were exposed to a low temperature of 18 °C for 6 h.
Cell culture medium was collected, and exosomes were isolated from cell debris, nucleic acids, and other large unimportant particles, by continuous centrifugation. The isolated exosomal proteins were analyzed to investigate the differences in expression of exosomal proteins between general conditions and low temperature stress. The morphology of the exosomes was observed using cryo-TEM. The existence of common exosome proteins and their effects on other cells were detected by Western blotting. Exosomal proteins were analyzed by two-dimensional electrophoresis (2-DE) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The protein information was found from the NCBInr protein database using the Mascot search engine.
2. Materials and Methods
2.1. Cell Culture and Treatment
The human glioblastoma cell line, U-87MG, was purchased from the Korean Cell Line Bank (KCLB, Seoul, Korea) and cultured in complete medium: Minimum Essential Medium (MEM; Welgene, Daegu, Korea) supplemented with 10% (v/v) fetal bovine serum (FBS; Welgene, Daegu, Korea) and 1% antibiotics (10,000 units/mL penicillin, 10 mg/mL streptomycin, and 25 μg/mL amphotericin B) (Welgene, Daegu, Korea). At ~70% confluency (total of four days), the U-87MG cells were separated into two groups for treatment. One group of cells was incubated in a 5% CO2 humidified incubator (Thermo Fisher Scientific, Waltham, MA, USA) at 37 °C, and maintained under these conditions. The other group was also incubated under the same conditions, however, was exposed to 18 °C in a low-temperature incubator (Vision Scientific, Daejeon, Korea). During an additional two-day culture, the cells were treated at 18 °C for 30 min, every 12 h. The media was collected.
2.2. Isolation and Purification of Exosomes
Each collected fraction of media was centrifuged at 500× g at room temperature (Hanil Science Industrial, Gangneung, Korea) for 10 min to eliminate floating particles and dead cells. Pellets were discarded, and the supernatant was again centrifuged at 800× g at room temperature for 10 min. At this point, dead cells were collected as a pellet. The collected fractions of supernatant were concentrated to a small volume using the Quixstand benchtop system (GE Healthcare, Buckinghamshire, UK) with a 50 kDa membrane filter (Hollow fiber cartridges; GE Healthcare, Buckinghamshire, UK). Concentrated solution was then centrifuged at 2000× g at room temperature for 20 min to remove cell debris and large particles. The resultant supernatants were subsequently centrifuged at 20,000× g at 4 °C using a Type 70 Ti rotor (Optima™ L-100 ultracentrifuge; Beckman Coulter, Brea, CA, USA) for 20 min. The pellets contained unimportant particles and vesicles larger than exosomes. The supernatant was centrifuged at 100,000× g at 4 °C for 70 min to settle the exosomes [20]. The supernatant was then discarded, and the resulting pellets were washed carefully in 1× phosphate-buffered saline (PBS; Welgene, Daegu, Korea). Resuspended pellets were centrifuged again at 100,000× g at 4 °C using a 90 Ti rotor (Beckman Coulter, Brea, CA, USA) for 70 min. Following removal of the supernatant, the pelleted exosomes were resuspended in 100 μL PBS and stored at −80 °C.
2.3. Cryo-Transmission Electron Microscopy (TEM)
A volume of 3–5 μL of each exosome sample suspended in PBS was transferred onto a holey carbon-coated grid. The grid was placed at ~85% humidity for 10 s and then plunge-frozen in liquid ethane prepared without ice crystals at liquid-nitrogen temperature (−196 °C) using a Vitrobot (FEI, Hillsboro, OR, USA). The grid was mounted onto a cryo-transfer specimen holder (Gatan, Pleasanton, CA, USA), at −175 °C. The sample was observed using a cryo-TEM (FEI, Hillsboro, OR, USA), operating at 200 kV. Low-dose images were recorded at a nominal magnification of 50,000×.
2.4. Two-Dimensional Electrophoresis (2-DE) and Gel Image Analysis
2-DE was carried out as described. Aliquots in sample buffer (7 M Urea, 2 M thiourea, 4.5% (w/v) 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 100 mM DTT, 40 mM Tris, pH 8.8, and trace of bromophenol blue) were applied to an immobilized pH 3–10 nonlinear gradient strip (Amersham Biosciences, Uppsala, Sweden). The samples (1 mg) were loaded. IEF was performed at 80,000 Vh. Then, 9%–16% linear gradient polyacrylamide gels electrophoresis (18 × 20 cm, 1.5 mm) was performed at a constant 40 mA, for approximately 5 h. The gels were fixed in 40% methanol and 5% phosphoric acid for 1 h and stained with Coomassie Brilliant Blue (CBB) G-250 for 12 h. The gels were destained with water, scanned in a Bio-Rad (Richmond, CA, USA) GS710 densitometer, and then analyzed using the Image Mater Platinum 5.0 image analysis program (Amersham Biosciences).
2.5. In-Gel Enzymatic Digestion and MALDI-TOF-MS
For peptide mass fingerprinting (PMF), the spots were excised from the stained gel and in-gel digestion was carried out. The excised spots were destained with 50 mM ammonium bicarbonate in 40% acetonitrile, and dried with a speed vac (Heto Lab Equipment, Allerod, Denmark). The destained spots were rehydrated in 12.5 ng/μL trypsin in 50 mM ammonium bicarbonate. The rehydrated spots were placed on ice for 45 min and treated with 50 mM ammonium bicarbonate (10 μL). The spots were then incubated at 37 °C for 12 h.
For MALDI-TOF-MS analysis, the peptides were desalted and concentrated using a POROS R2 and Oligo R3 column (Applied Biosystems, Fostercity, CA, USA). The column was washed sequentially with 70% acetonitrile, 100% acetonitrile, and 50 mM ammonium bicarbonate. The samples were applied and eluted with cyano-4-hydroxycinnamic acid (CHCA) (Sigma, St. Louis, MO, USA) dissolved in 70% acetonitrile and 2% formic acid onto the MALDI plate (Opti-TOF™ 384-well Insert, Applied Biosystems) [35]. MALDI-TOF-MS was performed on a 4800 MALDI-TOF/TOF™ Analyzer (Applied Biosystems) equipped with a 355-nm Nd:YAG laser (TOF analyzer pressure: approximately 7.6 × 10−7 Torr). The mass spectra were obtained in the reflection mode (accelerating voltage of 20 kV and the sum from either 500 laser pulses), and calibrated using the 4700 calibration mixture (Applied Biosystems).
2.6. Mascot Database Search
The database search criteria were as follows: taxonomy, Homo sapiens; fixed modification, cysteine carboxyamidomethylation; variable modification, methionine oxidation; 1 maximum missed cleavage allowed; 100 ppm MS tolerance.
The probability of the identification of a protein was based on the Mascot score. The protein score is –Log10 (P) (P is the probability that the match is observed at a random event). Protein scores greater than 66 are considered significant (p < 0.05).
2.7. Western Blotting Analysis
To confirm the isolation of exosome, proteins were separated by SDS-PAGE. After the exosome proteins were transferred onto a nitrocellulose membrane (Schleicher and Schuell, Keene, NH, USA), the membrane was blocked with 5% (w/v) non-fat dry milk in Tris-buffered saline (TBS)–0.1% Tween-20 (TBST) at 4 °C. Then, the membrane was incubated with an anti-HSP90 and an anti-CD63 antibody (Cell Signaling) for 5 h. The membrane was incubated with an anti-rabbit secondary antibody coupled to peroxidase (Cell signaling). After a 2 h-incubation at room temperature, the membrane was washed with TBST, and blots were detected with an enhanced chemiluminescence solution (ECL1; Amersham Biosciences).
3. Results
3.1. Isolation of Exosomes
The white-yellow pelleted exosomes were isolated from the culture media of both the control and the low temperature-treated U-87MG cells by continuous centrifugation. When the cells were grown to 70% confluency, approximately 16.7 μg exosomes were collected per 75-cm3 cell culture flask. It is especially noteworthy that the quantity of exosomes in the medium from cells exposed to low temperature stress was less than that from the non-treated cells.
3.2. Identification of Exosomes from U-87MG Cell Culture Medium by Cryo-Transmission Electron Microscopy (TEM)
The morphologically-intact vesicles were purified using buoyant density centrifugation. As can be seen, transmission electron microscopy revealed that most of the nanovesicles were small and had a characteristic doughnut morphology (Figure 1). The densitometric analysis showed that the mean diameter of the tumor-derived nanovesicles was 46 nm, which is consistent with the results of a previous study regarding tumor-derived exosomes [25,36].
3.3. Protein Analysis of U-87MG Exosomes by Immunoblotting
Recent research has analyzed the protein composition of exosomes refined from various sources, particularly from cell culture medium, by proteomics, Western blotting, and immunocytochemistry. This composition reflects the cell type from which they are released, in addition to the endosomal origin [11].
In the present study, it was found that U-87MG exosomes contain Hsp90 (heat shock protein 90), which is one of the most common heat-related proteins that exist in all branches of eukaryotes. This protein is a highly conserved molecular chaperone that assists other key proteins involved in apoptosis, survival, and growth pathways, to properly fold and stabilize proteins against heat and other environmental stresses [37,38]. The presence of chaperones such as Hsp90 could be driven by their co-sorting with other proteins [11]. In Figure 2, it can be seen that Hsp90 was increased in exosomes from the cells exposed to low temperature (L.T.) compared with those from the non-treated cells. This suggests that when the cells experience an external stimulus, such as a decrease in temperature, the protein composition changes, as well as the protein composition of their exosomes.
3.4. Characterization of Exosomal Proteins by Two-Dimensional Polyacrylamide Gel Electrophoresis
Of the many spots on the gels, the significant ones were analyzed using the Image Mater Platinum 5.0 image analysis program. There were several different spots between the two temperature conditions (Figure 3 and Figure 4). The spots on the control gel (exosomes from U-87MG cells incubated under normal conditions) were selected, numbered, and compared with spots in the same location on the L.T. gel (exosomes from U-87MG cells exposed to low temperature). Quantitative analysis was then performed. The spots that showed two-fold greater or less expression (% vol of gels) than the control are shown in Table 1. The quantitative differences were only determined when a matched spot showed the same degree of up- or downregulation in duplicate experiments.
Table 1.
(A) The proteins whose expression was increased in the L.T. gel. | ||||||||
Spot ID | Protein Description | Accession No. | Score | MW (Da) | pI | Coverage (%) | Matched Peptides No. | L.T./Ctr Ratio (% vol.) |
262 | calcium-dependent secretion activator 2 isoform b | gi|148839284 | 54 | 144,652 | 5.80 | 13 | 14 | 2.0 |
444 | hCG1817425 | gi|119590387 | 68 | 15,559 | 8.88 | 63 | 7 | 3.2 |
859 | armadillo repeat-containing protein 4 | gi|31657114 | 53 | 117,146 | 7.98 | 17 | 13 | 2.6 |
1098 | immunoglobulin heavy variable 5 | gi|371571045 | 54 | 10,996 | 9.10 | 62 | 6 | 2.3 |
(B) The proteins whose expression was decreased in the L.T. gel. | ||||||||
Spot ID | Protein Description | Accession No. | Score | MW (Da) | pI | Coverage (%) | Matched Peptides No. | Ctr/L.T. Ratio (% vol.) |
91 | collagen, type VI, alpha 1, isoform CRA_b | gi|119629727 | 76 | 109,602 | 5.26 | 24 | 19 | 3.6 |
282 | DNA topoisomerase I, mitochondrial isoform 2 | gi|386642871 | 56 | 59,178 | 9.18 | 26 | 10 | 3.4 |
293 | titin | gi|407139 | 62 | 524,823 | 8.06 | 8 | 28 | 3.5 |
322 | putative RNA-binding protein 15B | gi|54607124 | 66 | 97,432 | 9.86 | 21 | 13 | 2.2 |
496 | phosphoserine aminotransferase isoform 2 | gi|10863955 | 59 | 35,508 | 6.23 | 35 | 8 | 2.0 |
499 | Chain A, Substrate Induced Remodeling Of The Active Site Regulates HTRA1 Activity | gi|323714490 | 101 | 36,607 | 6.91 | 44 | 12 | 2.1 |
(C) The protein spots that were only present in the control gel. | ||||||||
Spot ID | Protein Description | Accession No. | Score | MW (Da) | pI | Coverage (%) | Matched Peptides No. | |
531 | coatomer protein complex, subunit beta 2 (beta prime), isoform CRA_b | gi|119599446 | 67 | 99,839 | 5.04 | 22 | 14 | |
536 | hypothetical protein FLJ40243, isoform CRA_a | gi|119576413 | 51 | 183,085 | 6.14 | 12 | 17 | |
(D) The protein spots that were only identified in the L.T. gel. | ||||||||
Spot ID | Protein Description | Accession No. | Score | MW (Da) | pI | Coverage (%) | Matched Peptides No. | |
371 | immunoglobulin gamma heavy chain variable region | gi|5051322 | 63 | 13,695 | 7.94 | 52 | 6 | |
372 | nuclear receptor ROR-alpha isoform b | gi|19743901 | 61 | 64,306 | 5.97 | 15 | 10 | |
701 | myosin, heavy chain 1, skeletal | gi|109731497 | 127 | 223,975 | 5.62 | 17 | 28 | |
701 | muscle, adult | gi|109731497 | 127 | 223,975 | 5.62 | 17 | 28 | |
965 | keratin, type I cytoskeletal 9 | gi|55956899 | 89 | 62,255 | 5.14 | 29 | 12 | |
1292 | Chain A, The Effect Of Metal Binding On The Structure Of Annexin V And Implications For Membrane Binding | gi|809185 | 112 | 35,840 | 4.94 | 38 | 14 |
3.5. Proteome Analysis by MALDI-TOF-MS and Mascot Search
The mass spectra were calibrated using the 4700 calibration mixture (Applied Biosystems). For analysis, the spectrum was internally calibrated with the trypsin peak (842.5 m/z, 2211.104 m/z). The meaningful proteins were found from the NCBInr database using the Mascot search engine (Matrix Science) (Table 1). With the input being taxonomy Homo sapiens, the protein information corresponding to significant spots was obtained.
There were some meaningful proteins with a protein score higher than 66 (Table 1). In spot No. 444, the protein expression was increased, whereas in spots No. 91, 322, and 499, the protein expression was decreased in the L.T. gel. With respect to spot No. 531, the protein was only present in the control gel, however, with spots No. 701, 965, and 1292, the protein was only present in the L.T. gel.
4. Discussion
To date, despite increasing interest in, and the significance of exosomes, there are no standard procedures for their isolation, detection, and characterization. The reason for this is that exosomes are nanometers in size and are barely detected by conventional methods. Therefore, the goal of the present study was to effectively isolate U-87MG exosomes from cell culture medium and characterize them by protein analysis.
As shown in the TEM images, the pelleted exosomes were isolated successfully by filtration, concentration of the cell culture medium, and consecutive centrifugation, which confirmed the existence of exosomes. The most common protein present in exosomes, Hsp90, was detected by Western blotting. Hsp90 was increased in exosomes exposed to a low temperature compared with exosomes incubated under normal conditions. According to 2-DE images and MALDI-TOF-MS, different proteins were detected between the control gel and the L.T. gel. In the L.T. gel, certain proteins showed an increase in expression, whereas others showed a decrease. Moreover, there were spots that were only present on one of the gels. On the L.T. gel, there was increased expression of calcium-dependent secretion activator 2 isoform b, hCG1817425, armadillo repeat-containing protein 4, and immunoglobulin heavy variable 5-a, partial. The proteins that were reduced on the L.T. gel were collagen alpha-1(VI), DNA topoisomerase I, titin, mitochondrial isoform 2, RNA-binding protein 15B, phosphoserine aminotransferase isoform 2, and Chain A, Substrate Induced Remodeling Of The Active Site Regulates HTRA1 Activity. The protein spots that were present only on the control gel were coatomer protein complex, subunit beta 2 (isoform CRA_b), and hypothetical protein FLJ40243 (isoform CRA_a). Whereas the proteins spots that were present only in the L.T. gel were immunoglobulin gamma heavy chain variable region, nuclear receptor ROR-alpha isoform b, myosin-heavy chain 1, skeletal muscle, keratin-type I cytoskeletal 9, and Chain A, The Effect Of Metal Binding On The Structure Of Annexin V And Implications For Membrane Binding.
This study provides the first proteome analysis of U-87MG exosome and its changes in response to low temperature. Malign tumor marker protein such as human chorionic gonadotropin (hCG) was detected in U-87MG exosome and increased in response to cold temperature stimulus [37]. Among the proteins that were detected in U-87MG exosome, coatomer protein complex subunit, collagen type VI, myosin heavy chain 1, keratin, annexin A5 type I collagen, type VI alpha 1 are constituent structural proteins with omnipresent occurrence in cells and extracellular matrix. Coatomer is a soluble seven-protein complex which is a precursor of coat protein I (COP I; retrograde transport from trans-Golgi apparatus to cis-Golgi and endoplasmic reticulum) [38]. COP I plays a key role in Golgi apparatus vesicle formation, Golgi budding, and vesicular trafficking [38]. Collagen VI is a distinctive constituent within the superfamily of collagenous proteins and forms a main class of tissue microfibrils [39]. Annexin A5 which is a calcium- and phospholipid-binding protein interacts with a metastasis-related protein, polycystin-1 both in vitro and in a cell culture model and induces suppression of tumor metastasis [40]. It was also shown that polycystin-1 co-localizes with E-cadherin at the cell-cell contacts, accelerating the recruitment of intracellular E-cadherin to reforming junctions [40]. These exosome proteins could be proposed as targets for the detection of a cancer biomarker [41,42,43].
5. Conclusions
Altogether, the investigation of exosome proteome derived from the U-87MG glioblastoma cells, and the changes in metastasis marker proteins such as hCG and annexin A5 under temperature stress, suggest a possibility that these proteins may be used as diagnostic markers.
Acknowledgments
This research was supported by a Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean Government (Program for Basic Science: 20110011014).
Author Contributions
Seyeon Park conceived and designed the experiments; Sohyun Chun and Seunghyun Ahn performed the experiments; Sohyun Chun, Seunghyun Ahn and Seyeon Park analyzed the data; Sohyun Chun wrote the paper. Seunghyun Ahn and Chang-Hwan Yeom validated, reviewed and edited the paper.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., Ratajczak M.Z. Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006;20:1487–1495. doi: 10.1038/sj.leu.2404296. [DOI] [PubMed] [Google Scholar]
- 2.Yamane A., Seetharam L., Yamaguchi S., Gotoh N., Takahashi T., Neufeld G., Shibuya M. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1) Oncogene. 1994;9:2683–2690. [PubMed] [Google Scholar]
- 3.Mantovani A., Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol. Today. 1989;10:370–375. doi: 10.1016/0167-5699(89)90270-3. [DOI] [PubMed] [Google Scholar]
- 4.Vidulescu C., Clejan S., O’Connor K.C. Vesicle traffic through intercellular bridges in DU 145 human prostate cancer cells. J. Cell. Mol. Med. 2004;8:388–396. doi: 10.1111/j.1582-4934.2004.tb00328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Sun H., Li H., Sadler P.J. Transferrin as a metal ion mediator. Chem. Rev. 1999;99:2817–2842. doi: 10.1021/cr980430w. [DOI] [PubMed] [Google Scholar]
- 6.Simpson R.J., Jensen S.S., Lim J.W.E. Proteomic profiling of exosomes: Current perspectives. Proteomics. 2008;8:4083–4099. doi: 10.1002/pmic.200800109. [DOI] [PubMed] [Google Scholar]
- 7.Johnstone R.M., Adam M., Hammond J.R., Orr L., Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes) J. Biol. Chem. 1987;262:9412–9420. [PubMed] [Google Scholar]
- 8.Kang D.J., Oh S.O., Ahn S.M., Lee B.H., Moon M.H. Proteomic analysis of exosomes from human neural stem cells by flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2008;7:3475–3480. doi: 10.1021/pr800225z. [DOI] [PubMed] [Google Scholar]
- 9.Van Der Pol E., Hoekstra A.G., Sturk A., Otto C., Van Leeuwen T.G., Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J. Thromb. Haemost. 2010;8:2596–2607. doi: 10.1111/j.1538-7836.2010.04074.x. [DOI] [PubMed] [Google Scholar]
- 10.Conde-Vancells J., Rodriguez-Suarez E., Embade N., Gil D., Matthiesen R., Valle M., Elortza F., Lu S.C., Mato J.M., Falcon-Perez J.M. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J. Proteome Res. 2008;7:5157–5166. doi: 10.1021/pr8004887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Van Niel G., Porto-Carreiro I., Simoesexosome S., Raposo G. Exosomes: A common pathway for a specialized function. J. Biochem. 2006;140:13–21. doi: 10.1093/jb/mvj128. [DOI] [PubMed] [Google Scholar]
- 12.Stobiecka M. Exosome and microvesicles: Extracellular frontiers of intercellular communication. In: Somasundaran P., editor. Encyclopedia of Surface and Colloid Science. 3rd ed. Taylor & Francis, CRC Press; Oxfordshire, UK: 2016. pp. 2632–2644. [Google Scholar]
- 13.Vella L.J., Sharples R.A., Lawson V.A., Masters C.L., Cappai R., Hi A.F. Packing of prions into exosomes is associated with a novel pathway of PrP processing. J. Pathol. 2007;211:582–590. doi: 10.1002/path.2145. [DOI] [PubMed] [Google Scholar]
- 14.Kadiu I., Narayanasamy P., Dash P.K., Zhang W., Gendelman H.E. Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. J. Immunol. 2012;189:744–754. doi: 10.4049/jimmunol.1102244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Rajendran L., Honsho M., Zahn T.R., Keller P., Geiger K.D., Verkade P., Simons K. Alzheimer’s disease β-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. USA. 2006;103:11172–11177. doi: 10.1073/pnas.0603838103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., Geuze H.J. B lymphocytes secrete antigen—Presenting vesicles. J. Exp. Med. 1996;183:1161–1172. doi: 10.1084/jem.183.3.1161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wubbolts R., Leckie R.S., Veenhuizen P.T.M., Schwarzmann G., Möbius W., Hoernschemeyer J., Slot J.W., Geuze H.J., Stoorvogel W. Proteomic and biochemical analyses of human B Cell-derived exosomes potential implications for their function and multivesicular body formation. J. Biol. Chem. 2003;278:10963–10972. doi: 10.1074/jbc.M207550200. [DOI] [PubMed] [Google Scholar]
- 18.Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J.J., Lötvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cell. Nat. Cell Biol. 2007;9:654–659. doi: 10.1038/ncb1596. [DOI] [PubMed] [Google Scholar]
- 19.Laulagnier K., Motta C., Hamdi S., Roy S., Fauvelle F., Pageaux J.F., Kobayashi T., Salles J.P., Perret B., Bonnerot C., et al. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem. J. 2004;380:161–171. doi: 10.1042/bj20031594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Théry C., Boussac M., Véron P., Ricciardi-Castagnoli P., Raposo G., Garin J., Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 2001;166:7309–7318. doi: 10.4049/jimmunol.166.12.7309. [DOI] [PubMed] [Google Scholar]
- 21.Blanchard N., Lankar D., Faure F., Regnault A., Dumont C., Raposo G., Hivroz C. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J. Immunol. 2002;168:3235–3241. doi: 10.4049/jimmunol.168.7.3235. [DOI] [PubMed] [Google Scholar]
- 22.Heijnen H.F.G., Schiel A.E., Fijnheer R., Geuze H.J., Sixma J.J. Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94:3791–3799. [PubMed] [Google Scholar]
- 23.Van Niel G., Raposo G., Candalh C., Boussac M., Hershberg R., Cerf-Bensussan N., Heyman M. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology. 2001;121:337–349. doi: 10.1053/gast.2001.26263. [DOI] [PubMed] [Google Scholar]
- 24.Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H., Raposo G. Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. USA. 2004;101:9683–9688. doi: 10.1073/pnas.0308413101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Andre F., Schartz N.E.C., Chaput N., Flament C., Raposo G., Amigorena S., Angevin E., Zitvogel L. Tumor-derived exosomes: A new source of tumor rejection antigens. Vaccine. 2002;20:A28–A31. doi: 10.1016/S0264-410X(02)00384-5. [DOI] [PubMed] [Google Scholar]
- 26.Fauré J., Lachenal G., Court M., Hirrlinger J., Chatellard-Causse C., Blot B., Grange J., Schoehn G., Goldberg Y., Boyer V., et al. Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 2006;31:642–648. doi: 10.1016/j.mcn.2005.12.003. [DOI] [PubMed] [Google Scholar]
- 27.Lässer C., Alikhani V.S., Ekström K., Eldh M., Paredes P.T., Bossios A., Sjöstrand M., Gabrielsson S., Lötvall J., Valadi H. Human saliva, plasma and breast milk exosomes contain RNA: Uptake by macrophages. J. Transl. Med. 2011 doi: 10.1186/1479-5876-9-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bard M.P., Hegmans J.P., Hemmes A., Luider T.M., Willemsen R., Severijnen L.A.A., van Meerbeeck J.P., Burgers S.A., Hoogsteden H.C., Lambrecht B.N. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 2004;31:114–121. doi: 10.1165/rcmb.2003-0238OC. [DOI] [PubMed] [Google Scholar]
- 29.Keller S., Ridinger J., Rupp A.K., Janssen J.W.G., Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J. Transl. Med. 2011 doi: 10.1186/1479-5876-9-86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Vella L.J., Greenwood D.L.V., Cappai R., Scheerlinck J.P.Y., Hill A.F. Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. Immunol. Immunopathol. 2008;124:385–393. doi: 10.1016/j.vetimm.2008.04.002. [DOI] [PubMed] [Google Scholar]
- 31.Gatti J.L., Métayer S., Belghazi M., Dacheux F., Dacheux J.L. Identification, proteomic profiling, and origin of ram epididymal fluid exosome-like vesicles. Biol. Reprod. 2005;72:1452–1465. doi: 10.1095/biolreprod.104.036426. [DOI] [PubMed] [Google Scholar]
- 32.Pisitkun T., Shen R.F., Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA. 2004;101:13368–13373. doi: 10.1073/pnas.0403453101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Clark M.J., Homer N., O’Connor B.D., Chen Z., Eskin A., Lee H., Merriman B., Nelson S.F. U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line. PLoS Genet. 2010;6:e1000832. doi: 10.1371/journal.pgen.1000832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Mathivanan S., Ji H., Simpson R.J. Exosomes: Extracellular organelles important in intercellular communication. J. Proteom. 2010;73:1907–1920. doi: 10.1016/j.jprot.2010.06.006. [DOI] [PubMed] [Google Scholar]
- 35.Choi B.K., Cho Y.M., Bae S.H., Zoubaulis C.C., Paik Y.K. Single-step perfusion chromatography with a throughput potential for enhanced peptide detection by matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics. 2003;3:1955–1961. doi: 10.1002/pmic.200300558. [DOI] [PubMed] [Google Scholar]
- 36.Simons M., Raposo G. Exosomes vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 2009;21:575–581. doi: 10.1016/j.ceb.2009.03.007. [DOI] [PubMed] [Google Scholar]
- 37.Cole L.A. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod. Biol. Endocrinol. 2009 doi: 10.1186/1477-7827-7-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Stenbeck G., Harter C., Brecht A., Herrmann D., Lottspeich F., Orci L., Wieland F.T. beta’-COP, a novel subunit of coatomer. EMBO J. 1993;12:2841–2845. doi: 10.1002/j.1460-2075.1993.tb05945.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mayne R., Burgeson R.E. Structure and Function of Collagen Types. Academic Press; Orlando, FL, USA: 1987. pp. 105–143. [Google Scholar]
- 40.Markoff A., Bogdanova N., Knop M., Rüffer C., Kenis H., Lux P., Reutelingsperger C., Todorov V., Dworniczak B., Horst J., et al. Annexin A5 interacts with polycystin-1 and interferes with the polycystin-1 stimulated recruitment of E-cadherin into adherens junctions. J. Mol. Biol. 2007;369:954–966. doi: 10.1016/j.jmb.2007.03.070. [DOI] [PubMed] [Google Scholar]
- 41.Stobiecka M., Chalupa A., Dworakowska B. Piezometric biosensors for anti-apoptotic protein survivin based on buried positive-potential barrier and immobilized monoclonal antibodies. Biosens. Bioelectron. 2016;84:37–43. doi: 10.1016/j.bios.2015.10.041. [DOI] [PubMed] [Google Scholar]
- 42.Stobiecka M., Dworakowska B., Jakiela S., Lukasiak A., Chalupa A., Zembrzycki K. Sensing of survivin mRNA in malignant astrocytes using graphene oxide nanocarrier-supported oligonucleotide molecular beacons. Sens. Actuators B. 2016;235:136–145. doi: 10.1016/j.snb.2016.04.176. [DOI] [Google Scholar]
- 43.Stobiecka M., Chalupa A. DNA Strand replacement mechanism in molecular beacons encoded for the detection of cancer biomarkers. Phys. Chem. B. 2016;120:4782–4790. doi: 10.1021/acs.jpcb.6b03475. [DOI] [PubMed] [Google Scholar]